Undoubtedly from the recommendations from the National Advisory Council on Innovation and Entrepreneurship (NACIE), and other works directed at the promise of proof of concept centers like the IMPACT paper, “The i6 Challenge is a multi-agency grant that encourages and rewards innovative, groundbreaking ideas that accelerate technology commercialization, new venture formation, job creation, and economic growth across the United States. […]
Fifteen promising innovative technologies just got a $40,000 boost. For the first round of the new fiscal year, the Utah Governor’s Office of Economic Development (GOED) approved $600,000 of grants in support of new technology and research that universities and university licensees are seeking to take to market. The grants are designed to help build companies and create quality new jobs from groundbreaking innovation. […]
The European Research Council (ERC) will release a new round of proof of concept grants to 33 research projects. Each project will receive EUR 150,000 that is put towards commercial translation such as IP dilligence, market research, and commercial validations. There was a yield rate, or projects funded vs proposed, in this round of 44%.
‘The “Proof of Concept” scheme is gathering speed,’ adds President of the ERC, Professor Helga Nowotny. ‘With relatively little investment, it helps to harvest the very best ideas coming from frontier research, and takes them one decisive step further in the direction of potential innovation. This new funding initiative has also inspired more of our grantees to explore the possibilities of the results and findings they have obtained. It leads them to ask the question: “What follows from my research?” In the longer term, such a change in attitude will be good for Europe and will strengthen links between research and society.’ […]
Last week, we held our second event in the Gap Fund Managers iWorkshop Series that took a detailed look at the process behind runnning university-affiliated gap funds. Three of your colleagues
- Michael Rusnak, U Rochester Medical Center
- John Banta, illinoisVENTURES
- Monique Yoakim-Turk, Children’s Boston
led us through their promotion, evaluation, decision-making (scorecards,advisory boards), and marketing associated with their funds.
The Innovation Research Center at the University of New Hampshire has awarded a Granite State Technology Innovation Grant to ArgenTech Solutions, Inc. (AgTS) to help develop a high-performance, photoluminescent powder coating additive suitable for advanced safety and military applications.
THE University of York is to encourage a new generation of social entrepreneurs.
The university is one of 56 universities to take part in a pilot of a national programme to encourage the creation of social enterprises, self-sustaining initiatives to achieve social purposes rather than just make a profit. […]
IP Shakti, LLC, a Princeton based innovation fund, offers a new approach for investing in the early stages of life science and biomedical innovation.
University inventors often face the “valley of death” funding gap when they look to develop a new innovation. IP Shakti is now an option for medical device innovators when venture capital and other funding sources are unwilling or unable help.
“The launch of IP Shakti could not come at a more critical time,” said Dr. Dipanjan Nag, CEO and President of IP Shakti. “Due to fundamental challenges in venture capital investing, early stage inventions in biotechnology and their corresponding smaller initial investment requirements are increasingly overlooked or rejected by venture capital in favor of more developed technologies. This exacerbates the “valley of death” funding gap after a startup company is created and before a steady stream of company revenue exists.” […]
Last week, the University of Michigan announced a new Center for the Discovery of New Medicines (CDNM) to help speed the school’s research findings to the marketplace. The new initiative is a cross-departmental effort to leverage resources like former Pfizer researchers, unique libraries of compounds, and a culture of data sharing to streamline early-stage drug discovery in an age where big pharma is increasingly reluctant to invest in it.
“Our goal is to really speed up drug discovery at the university,” says Rick Neubig, professor of pharmacology and director of the CDNM. “There’s tremendous interest in that here.”
Neubig says that though there’s a lot of cutting-edge work already being done at U-M in the area of drug discovery, it’s fragmented. The goal of the new center is to serve as a catalyzing hub for research scientists, where they can collaborate and connect with private-sector partners on the journey toward commercialization.